StoxSai Life Sciences vs Aster DM Quality Care: share price & financials comparison
NSE: SAILIFE vs ASTERDM · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Sai Life Sciences vs Aster DM Quality Care at a glance
Sai Life Sciences (SAILIFE) has a market capitalisation of ₹37,919 Cr, against ₹36,950 Cr for Aster DM Quality Care (ASTERDM). Over the past year Sai Life Sciences has returned +94.7%, compared with +1.9% for Aster DM Quality Care. On valuation, Aster DM Quality Care trades at a lower P/E of 115.9 versus 187.2. Sai Life Sciences earns a higher return on equity (7.5% vs 7.0%). Sai Life Sciences comes out ahead on profitability, growth, momentum and technicals. Aster DM Quality Care comes out ahead on size, valuation and financial health. Across the scored metrics below, Sai Life Sciences leads on 8 and Aster DM Quality Care on 4. On StoxGud's 10-point checklist, Sai Life Sciences scores 6/10 and Aster DM Quality Care scores 5/10.
| Metric | Sai Life Sciences | Aster DM Quality Care |
|---|---|---|
| Size | ||
| Market cap | ₹37,919 Cr | ₹36,950 Cr |
| Revenue (latest FY) | ₹2,192 Cr | ₹4,643 Cr |
| Net profit (latest FY) | ₹349 Cr | ₹388 Cr |
| Valuation | ||
| P/E | 187.2 | 115.9 |
| P/B | 14.11 | 8.08 |
| Dividend yield | — | 0.15% |
| Profitability | ||
| Return on equity | 7.5% | 7.0% |
| Net profit margin | 8.5% | 6.5% |
| Operating margin | 29.5% | 19.6% |
| Growth | ||
| Revenue growth (YoY) | +22.5% | +21.6% |
| Net profit growth (YoY) | — | -81.2% |
| Revenue CAGR (multi-year) | — | -11.6% |
| Financial health | ||
| Debt to equity | 0.17 | 0.15 |
| Momentum | ||
| 1-month return | +14.3% | +4.8% |
| 1-year return | +94.7% | +1.9% |
| 3-year CAGR | — | +28.6% |
| 5-year CAGR | — | +30.1% |
| Distance from 52W high | +0.0% | -18.0% |
| Technicals | ||
| RSI (14) | 93 | 64 |
| Price vs 200-day avg | +47.1% | -0.4% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Sai Life Sciences | Aster DM Quality Care |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✓ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 6/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Sai Life Sciences or Aster DM Quality Care?
Sai Life Sciences has a market cap of ₹37,919 Cr and Aster DM Quality Care has a market cap of ₹36,950 Cr as of 06 Nov 2026.
Which has a lower P/E, Sai Life Sciences or Aster DM Quality Care?
Aster DM Quality Care has the lower P/E: Sai Life Sciences trades at 187.2 and Aster DM Quality Care at 115.9.
Which gave better returns in the last year, Sai Life Sciences or Aster DM Quality Care?
Sai Life Sciences did better: Sai Life Sciences returned +94.7% and Aster DM Quality Care returned +1.9% over one year.
Is Sai Life Sciences or Aster DM Quality Care a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Sai Life Sciences scores 6/10 and Aster DM Quality Care scores 5/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.